OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The importance of functional genomics studies in precision rheumatology	150
Editorial Board	67
Rehabilitation interventions in osteoarthritis	60
Employment outcomes in systemic sclerosis	60
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit	50
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	45
Change of the microvascularization in systemic sclerosis, a matter of air	42
Update of imaging in the assessment of axial spondyloarthritis	36
Novel therapies – IMID Co-morbidities	34
Rheumatic manifestations of HIV/AIDS	32
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus	32
Epidemiology of rheumatic diseases in tropical populations	32
The inequity of global healthcare in pediatric rheumatology	28
Environmental factors and rheumatic diseases	27
Novel therapies in Sjögren’s disease: A systematic review of the literature	26
Pathophysiology and immunolgical basis of axial spondyloarthritis	25
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases	24
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus	22
The microbiome and systemic sclerosis: A review of current evidence	22
Index for PART A	22
Osteoporosis in 2022: Care gaps to screening and personalised medicine	22
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	22
The role of calcium crystals and their effect on osteoarthritis pathogenesis	22
Genetics of rheumatoid arthritis	21
Genetics of osteoarthritis	21

The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights	20
Editorial Board	20
Patient-reported outcomes in vasculitis	20
Index	20
Editorial Board	19
Novel therapies and innovation for systemic sclerosis skin ulceration	19
Preclinical RA: How to halt its progression	18
Imaging of crystal-induced arthropathies in 2025	18
Systemic lupus erythematosus	18
Where is bone science taking us?	18
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?	18
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps	18
Diagnostic delay in axial spondylarthritis: A lost battle?	17
Editorial Board	17
The burden of osteoarthritis: Is it a rising problem?	17
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists	17
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment	16
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	16
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	16
Pregnancy & neonatal outcomes in spondyloarthritis	16
Role of diet in hyperuricemia and gout	16
Editorial Board	15
Problems with “Problems with opioids beyond misuse”	15
Fecal incontinence and scleroderma: Pathogenesis and unmet needs	15
Imaging rheumatology: Emerging tools and expanding applications	15
New and future therapies: Changes in the therapeutic armamentarium for SLE	15
Exercise in myositis: What is important, the prescription or the person?	15
Infection associated Vasculitides	15
Pregnancy in systemic lupus erythematosus	14
Calcium pyrophosphate deposition (CPPD) disease – Treatment options	14
Risk for osteoporosis and fracture with glucocorticoids	13
Innovations in systemic sclerosis	13
Best practice and research advances in many aspects of rheumatology	13
Editorial Board	13
Index	13
Granzyme K+ CD8 T cells in autoimmunity	13
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment	13
What the rheumatologist needs to know about skin biopsy	12
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances	12
Pharmacogenetics of therapies in rheumatoid arthritis: An update	12
Regenerative methods in osteoarthritis	12
Review for best practice in clinical rheumatology juvenile systemic sclerosis – Updates and practice points	12
Treatment of rheumatic adverse events of cancer immunotherapy	11
Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management	11
Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	11
Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis	11
Synovial fluid analysis: Relevance for daily clinical practice	11
Idiopathic inflammatory myopathies: Progress, challenges, and future perspectives	11
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus	10
When are patients with osteoarthritis referred for surgery?	10

A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis	10
Impact of sex and gender on axSpA diagnosis and outcomes	10
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future	10
Pain in osteoarthritis from a symptom to a disease	10
TNFR2 signalling in inflammatory diseases	9
Editorial Board	9
Recent targets of osteoarthritis research	9
Practical utilization of sonography for the assessment of muscle diseases in rheumatology	9
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	9
Index	9
Femoroacetabular impingement – What the rheumatologist needs to know	8
Muscle imaging in myositis: MRI, US, and PET	8
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	8
Interferonopathies: From concept to clinical practice	8
CARD9 in the pathogenesis of axial spondyloarthritis	8
Pathogenesis of calcium pyrophosphate deposition disease	8
Imaging in sarcoid disease	7
Insights into the genetic landscape of systemic sclerosis	7
Pain syndromes	7
Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies	7
Pain mechanisms for the practicing rheumatologist	7
Novel therapies in axial spondyloarthritis	7
Preface: Pediatric rheumatology	7
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission	6
Tropical pyomyositis	6
The global burden of fragility fractures – what are the differences, and where are the gaps	6
Editorial Board	5
Advances in imaging techniques for Sjogren's disease	5
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	5
Best practice in rheumatology new developments in ultrasound and MRI imaging of pediatric rheumatic diseases	5
Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes	5
Interstitial lung disease imaging for autoimmune diseases	5
Pre-RA: Can early diagnosis lead to prevention?	5
Myofascial pain – A major player in musculoskeletal pain	5
Musculoskeletal manifestations in leprosy	5
Treatment overview of axial spondyloarthritis in 2023	5
Cardiovascular risk in vasculitis	5
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)	5
Non-coding DNA variants for risk in lupus	5
Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases	5
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question	5
Osteoporosis and fragility fractures – Why is there still avoidable disability and death?	4
Practical approaches for clinicians in chronic pain management: Strategies and solutions	4
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	4
Highlights of advancement in Rheumatoid Arthritis research and clinical practice	4
What is new in pharmacological treatment for osteoarthritis?	4
Vascular ultrasound in rheumatology practice	4
Genetics of vasculitis	4
Cancer and myositis: Who, when, and how to screen	4
Editorial Board	4
Challenges in the diagnosis of axial spondyloarthritis	4
How to treat monogenic SLE?	4
Microbiota and immune dynamics in rheumatoid arthritis: Mechanisms and therapeutic potential	4
Deficiency of adenosine deaminase 2 (DADA2): Review	4